Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.



  • Veni grant for Yoshitaka Hiruma

    Yoshitaka Hiruma, postdoc in the group of Anastassis Perrakis, will receive a Veni grant from the Netherlands Organisation for Scientific Research (Dutch abbreviation: NWO). He will use the grant of 250.000 Euro to further study the role of the Mps1 protein during cell division.

    Read More
  • Novel therapeutic target proposed to increase the efficacy of taxane chemotherapy

    Researchers from NKI, in collaboration with the biotech company NTRC and University Medical Center Utrecht, have discovered that inhibition of the protein kinase TTK, a protein involved in chromosome segregation, increases the efficacy of taxane chemotherapy in models of triple-negative breast cancer.

    Read More
  • More news

Comprehensive Cancer Centre

'The Netherlands Cancer Institute, a center of excellence for the benefit of cancer patients.'

Support Us